Connect Sign In
Pregabalin, Urine
Ordering Recommendation
Useful for general testing in contexts of compliance and/or abuse. Preferred test to follow-up presumptive results.
New York DOH Approval Status
Specimen Required
Random urine.
Transfer 1 mL urine to an ARUP Standard Transport Tube. (Min: 0.6 mL)
Refrigerated.
Ambient: 1 month; Refrigerated: 1 month; Frozen: 1 month
Methodology
Quantitative Liquid Chromatography-Tandem Mass Spectrometry
Performed
Wed, Sat
Reported
1-7 days
Reference Interval
By report
Interpretive Data
Positive cutoff: 5.0 µg/mL
For medical purposes only; not valid for forensic use.
The absence of expected drug(s) and/or drug metabolite(s) may indicate non-compliance, inappropriate timing of specimen collection relative to drug administration, poor drug absorption, diluted/adulterated urine, or limitations of testing. The concentration value must be greater than or equal to the cutoff to be reported as a quantitative result. Interpretive questions should be directed to the laboratory.
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
Laboratory Developed Test (LDT)
Note
Hotline History
Hotline History
CPT Codes
80366 (Alt code: G0480)
Components
| Component Test Code* | Component Chart Name | LOINC |
|---|---|---|
| 2012230 | Pregabalin, Urine | 64125-8 |
Aliases
- Lyrica
